Who owns the NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES trademark?

The NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES trademark is owned by Angiex, Inc..

What class is the NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES trademark registered in?

The NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES?

The USPTO serial number for NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES is 97296549.

What is the registration number for NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES?

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES is registered under USPTO registration number 7064074.

NUC

USPTO Trademark Record

REGISTERED

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

SN 97296549·Reg 7064074·Filed Mar 04, 2022

Owner Angiex, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES (Serial No. 97296549), Registration No. 7064074, is a registered US trademark filed on Mar 04, 2022 by Angiex, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: May 23, 2029

Mark Intelligence

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES (Reg. #7064074) is a registered US trademark that has been protecting its owner, Angiex, Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Mar 04, 2022

SERIAL

97296549

REG#

7064074

REGISTERED

May 23, 2023

Owner

Applicant

Angiex, Inc.

Entity

Corporation

State

Address

150 CambridgePark Drive, 5th Floor, Cambridge, MA, 02140

Country

Attorney

NameChelsea E. Carbone

Law firm

Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI

Docket

52628-TM1007

Address

650 PAGE MILL ROAD, PALO ALTO, CA 94304-1050, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMar 04, 2022

Serial Number97296549

Registration No.7064074

Registration DateMay 23, 2023

Status DateMay 23, 2023

Mark TypeStandard characters

Attorney Docket52628-TM1007

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 10, 2020

First use in commerce: Jan 10, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

REGISTERED-SUPPLEMENTAL REGISTER

May 23, 2023

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 23, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 21, 2023

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 21, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 21, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Apr 21, 2023

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 21, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 21, 2023

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 17, 2023

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Apr 12, 2023

ASSIGNED TO LIE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Mar 31, 2023

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Mar 30, 2023

USE AMENDMENT ACCEPTED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Mar 30, 2023

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

USE AMENDMENT FILED

Mar 07, 2023

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Mar 07, 2023

AMENDMENT TO USE PROCESSING COMPLETE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 07, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS AMENDMENT OF USE RECEIVED

Mar 06, 2023

TEAS AMENDMENT OF USE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 06, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 06, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Dec 22, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 22, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 22, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 15, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 09, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 08, 2022

NEW APPLICATION ENTERED

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Angiex, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Chelsea E. Carbone

Resources

Company